Naringenin triacetate

CAS No. 3682-04-0

Naringenin triacetate( —— )

Catalog No. M30951 CAS No. 3682-04-0

Naringenin triacetate exhibits a better binding affinity with multiple crystal structures of first bromodomain BRD4 (BRD4 BD1) when compared with the known inhibitors.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 102 In Stock
10MG 163 In Stock
25MG 274 In Stock
50MG 402 In Stock
100MG 582 In Stock
200MG 821 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Naringenin triacetate
  • Note
    Research use only, not for human use.
  • Brief Description
    Naringenin triacetate exhibits a better binding affinity with multiple crystal structures of first bromodomain BRD4 (BRD4 BD1) when compared with the known inhibitors.
  • Description
    Naringenin triacetate exhibits a better binding affinity with multiple crystal structures of first bromodomain BRD4 (BRD4 BD1) when compared with the known inhibitors.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    3682-04-0
  • Formula Weight
    398.4
  • Molecular Formula
    C21H18O8
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (251.03 mM)
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Diaveridine

    Diaveridine (DVD) is a popular antibacterial synergist that is widely used in combination with sulfonamide.

  • Gap19 TFA

    Gap19 TFA is a peptide derived from nine amino acids of Cx43 cytoplasmic ring (CL), an effective, selective connexin 43 (Cx43) half-channel blocker.

  • Levobunolol hydrochl...

    Levobunolol hydrochloride is a non-selective beta-blocker and is used topically to manage glaucoma.